Cytokinetics
CYTK
CYTK
101 hedge funds and large institutions have $323M invested in Cytokinetics in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 35 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less call options, than puts
Call options by funds: $358K | Put options by funds: $423K
17% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 35
Holders
101
Holding in Top 10
1
Calls
$358K
Puts
$423K
Top Buyers
| 1 | +$8.5M | |
| 2 | +$3.96M | |
| 3 | +$1.96M | |
| 4 |
GC
Globeflex Capital
San Diego,
California
|
+$1.69M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.66M |
Top Sellers
| 1 | -$9.62M | |
| 2 | -$2.55M | |
| 3 | -$1.77M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.4M |
| 5 |
Millennium Management
New York
|
-$1.22M |